Susquehanna International Group, LLP Maia Biotechnology, Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 11,649 shares of MAIA stock, worth $21,550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,649Holding current value
$21,550% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MAIA
# of Institutions
19Shares Held
1.38MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA583KShares$1.08 Million0.0% of portfolio
-
Halter Ferguson Financial Inc. Carmel, IN241KShares$445,5130.2% of portfolio
-
Geode Capital Management, LLC Boston, MA198KShares$365,4190.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$145,2630.0% of portfolio
-
Centric Wealth Management68.2KShares$126,2050.04% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $20.2M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...